Skip to main content
Top
Published in: Neurology and Therapy 2/2018

Open Access 01-12-2018 | Commentary

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier

Authors: David Yeandle, Peter Rieckmann, Gavin Giovannoni, Nektaria Alexandri, Dawn Langdon

Published in: Neurology and Therapy | Issue 2/2018

Login to get access

Abstract

A debate on shared decision making in multiple sclerosis (MS) was led by a patient advocate and leading neurologists from the MS in the 21st Century Steering Group. Key themes and salient points which emerged from the debate and audience discussions are reported in this article. Arguments against shared decision making included the fact that physicians study and practice for years to reach their level of expertise, and that the level of understanding required to make these decisions may not be possible to communicate to patients within time-limited consultations. Furthermore, unreliable online information, information overload or information with marketing bias may also cloud patients’ judgements. Arguments for patient engagement focussed on how ownership of decisions can lead to improved adherence and outcomes, and a strengthening of the physician–patient relationship. Shared decision making requires educating patients to make informed decisions and to understand the risks and consequences of their choices. However, shared decision making may not be the correct option for every patient, and the level of involvement must be driven by the patient. To support patients’ engagement and promote responsible management of their condition, physicians need to (1) foster and maintain a positive, ongoing relationship with their patients, and (2) provide patients with timely, accurate, and understandable information. There was broad agreement that the patient voice should be heard more in discussions around the future of MS care. MS in the 21st Century offers a model for patient involvement in partnership with MS healthcare specialists, and the steering group is currently considering these issues and developing tools and solutions to enhance patient–physician communication and relationships.
Funding Merck KGaA, Darmstadt, Germany.
Literature
2.
go back to reference Carman KL, Dardess P, Maurer M, Sofaer S, Adams K, Bechtel C, Sweeney J. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff. 2013;32(2):223–31.CrossRef Carman KL, Dardess P, Maurer M, Sofaer S, Adams K, Bechtel C, Sweeney J. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff. 2013;32(2):223–31.CrossRef
3.
go back to reference Köpke S, Giordano A, Veronese S, Christin Rahn A, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, Patti F, Pekmezovic T, Sastre-Garriga J, Vosburgh J, Voltz R, Bay J, Oliver DJ, Solari A. Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis. Eur J Neurol. 2018. https://doi.org/10.1111/ene.13760.CrossRefPubMed Köpke S, Giordano A, Veronese S, Christin Rahn A, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, Patti F, Pekmezovic T, Sastre-Garriga J, Vosburgh J, Voltz R, Bay J, Oliver DJ, Solari A. Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis. Eur J Neurol. 2018. https://​doi.​org/​10.​1111/​ene.​13760.CrossRefPubMed
6.
go back to reference Reen GK, Silber E, Langdon DW. Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review. Patient Educ Couns. 2017;100(6):1031–48.CrossRefPubMed Reen GK, Silber E, Langdon DW. Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic review. Patient Educ Couns. 2017;100(6):1031–48.CrossRefPubMed
7.
go back to reference Reen GK, Silber E, Langdon DW. Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review. J Neurol Sci. 2017;375:107–22.CrossRefPubMed Reen GK, Silber E, Langdon DW. Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review. J Neurol Sci. 2017;375:107–22.CrossRefPubMed
8.
go back to reference Reen GK, Silber E, Langdon DW. Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis. Value Health. 2018;21(7):762–6.CrossRefPubMed Reen GK, Silber E, Langdon DW. Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple Sclerosis. Value Health. 2018;21(7):762–6.CrossRefPubMed
9.
go back to reference Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, Aston K, Bauer B, Demory C, Giambastiani MP, Hlavacova J, Nouvet-Gire J, Pepper G, Pontaga M, Rogan E, Rogalski C, van Galen P, Ben-Amor AF. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Mult Scler Relat Disord. 2018;19:153–60.CrossRefPubMed Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Kesselring J, Kobelt G, Langdon D, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P, Aston K, Bauer B, Demory C, Giambastiani MP, Hlavacova J, Nouvet-Gire J, Pepper G, Pontaga M, Rogan E, Rogalski C, van Galen P, Ben-Amor AF. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Mult Scler Relat Disord. 2018;19:153–60.CrossRefPubMed
10.
go back to reference Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. Mult Scler Rel Disord. 2015;4(3):202–18.CrossRef Rieckmann P, Boyko A, Centonze D, Elovaara I, Giovannoni G, Havrdová E, Hommes O, Kesselring J, Kobelt G, Langdon D, LeLorier J, Morrow SA, Oreja-Guevara C, Schippling S, Thalheim C, Thompson H, Vermersch P. Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group. Mult Scler Rel Disord. 2015;4(3):202–18.CrossRef
11.
go back to reference Heesen C, Köpke S, Solari A, Geiger F, Kasper J. Patient autonomy in multiple sclerosis–possible goals and assessment strategies. J Neurol Sci. 2013;331(1–2):2–9.CrossRefPubMed Heesen C, Köpke S, Solari A, Geiger F, Kasper J. Patient autonomy in multiple sclerosis–possible goals and assessment strategies. J Neurol Sci. 2013;331(1–2):2–9.CrossRefPubMed
12.
go back to reference D'Amico E, Leone C, Patti F. Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosis. Funct Neurol. 2016;31(1):21–3.PubMedPubMedCentral D'Amico E, Leone C, Patti F. Disability may influence patient willingness to participate in decision making on first-line therapy in multiple sclerosis. Funct Neurol. 2016;31(1):21–3.PubMedPubMedCentral
13.
go back to reference National Collaborating Centre for Chronic Conditions. Multiple sclerosis: National clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians (UK); 2004. National Collaborating Centre for Chronic Conditions. Multiple sclerosis: National clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians (UK); 2004.
14.
go back to reference Rosenbaum L. The Paternalism Preference-Choosing Unshared Decision Making. N Engl J Med. 2015;373(7):589–92.CrossRefPubMed Rosenbaum L. The Paternalism Preference-Choosing Unshared Decision Making. N Engl J Med. 2015;373(7):589–92.CrossRefPubMed
17.
go back to reference Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, Esmat K, Khalifa A, Sahraian MA, Szólics M, Altahan A, Yamout BI, Rieckmann P, Daif A. Future of management of multiple sclerosis in the Middle East: a consensus view from specialists in ten countries. Mult Scler Int. 2013;2013:952321.PubMedPubMedCentral Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, Esmat K, Khalifa A, Sahraian MA, Szólics M, Altahan A, Yamout BI, Rieckmann P, Daif A. Future of management of multiple sclerosis in the Middle East: a consensus view from specialists in ten countries. Mult Scler Int. 2013;2013:952321.PubMedPubMedCentral
21.
go back to reference Meterko M, Wright S, Lin H, Lowy E, Cleary PD. Mortality among patients with acute myocardial infarction: the influences of patient-centered care and evidence-based medicine. Health Serv Res. 2010;45:1188–204.CrossRefPubMedPubMedCentral Meterko M, Wright S, Lin H, Lowy E, Cleary PD. Mortality among patients with acute myocardial infarction: the influences of patient-centered care and evidence-based medicine. Health Serv Res. 2010;45:1188–204.CrossRefPubMedPubMedCentral
22.
go back to reference Burks J, Marshall TS, Ye X. Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis. Clinicoecon Outcomes Res. 2017;9:251–60.CrossRefPubMedPubMedCentral Burks J, Marshall TS, Ye X. Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis. Clinicoecon Outcomes Res. 2017;9:251–60.CrossRefPubMedPubMedCentral
23.
go back to reference Evans C, Marrie RA, Zhu F, Leung S, Lu X, Melesse DY, Kingwell E, Zhao Y, Tremlett H. Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Mult Scler Relat Disord. 2016;8:78–85.CrossRefPubMed Evans C, Marrie RA, Zhu F, Leung S, Lu X, Melesse DY, Kingwell E, Zhao Y, Tremlett H. Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Mult Scler Relat Disord. 2016;8:78–85.CrossRefPubMed
24.
go back to reference Yermakov S, Davis M, Calnan M, Fay M, Cox-Buckley B, Sarda S, Duh MS, Iyer R. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. J Med Econ. 2015;18(9):711–20.CrossRefPubMed Yermakov S, Davis M, Calnan M, Fay M, Cox-Buckley B, Sarda S, Duh MS, Iyer R. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis. J Med Econ. 2015;18(9):711–20.CrossRefPubMed
25.
go back to reference Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla AA, Karkare SU, McGuiness CB, Korn JR. Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study. PLoS One. 2014;9(2):e88472.CrossRefPubMedPubMedCentral Bergvall N, Makin C, Lahoz R, Agashivala N, Pradhan A, Capkun G, Petrilla AA, Karkare SU, McGuiness CB, Korn JR. Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study. PLoS One. 2014;9(2):e88472.CrossRefPubMedPubMedCentral
26.
go back to reference Lugaresi A, Ziemssen T, Oreja-Guevara C, Thomas D, Verdun E. Improving patient–physician dialog: commentary on the results of the MS Choices survey. Patient Prefer Adherence. 2012;6:143–52.CrossRefPubMedPubMedCentral Lugaresi A, Ziemssen T, Oreja-Guevara C, Thomas D, Verdun E. Improving patient–physician dialog: commentary on the results of the MS Choices survey. Patient Prefer Adherence. 2012;6:143–52.CrossRefPubMedPubMedCentral
27.
go back to reference Colligan E, Metzler A, Tiryaki E. Shared decision-making in multiple sclerosis. Mult Scler J. 2017;23(2):185–90.CrossRef Colligan E, Metzler A, Tiryaki E. Shared decision-making in multiple sclerosis. Mult Scler J. 2017;23(2):185–90.CrossRef
29.
go back to reference Lavorgna L, Lanzillo R, Brescia Morra V, Abbadessa G, Tedeschi G, Bonavita S. Social Media and Multiple Sclerosis in the Posttruth Age. Interact J Med Res. 2017;6(2):e18.CrossRefPubMedPubMedCentral Lavorgna L, Lanzillo R, Brescia Morra V, Abbadessa G, Tedeschi G, Bonavita S. Social Media and Multiple Sclerosis in the Posttruth Age. Interact J Med Res. 2017;6(2):e18.CrossRefPubMedPubMedCentral
30.
go back to reference de Seze J, Borgel F, Brudon F. Patient perceptions of multiple sclerosis and its treatment. Patient Prefer Adherence. 2012;6:263–73.PubMedPubMedCentral de Seze J, Borgel F, Brudon F. Patient perceptions of multiple sclerosis and its treatment. Patient Prefer Adherence. 2012;6:263–73.PubMedPubMedCentral
31.
go back to reference Köpke S, Solari A, Rahn A, Khan F, Heesen C, Giordano A. Information provision for people with multiple sclerosis. Cochrane Database Syst Rev. 2018;10:CD008757.PubMed Köpke S, Solari A, Rahn A, Khan F, Heesen C, Giordano A. Information provision for people with multiple sclerosis. Cochrane Database Syst Rev. 2018;10:CD008757.PubMed
32.
go back to reference Ceuninck van Capelle A, Meide HV. Vosman FJH, Visser LH. A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS). PLoS One. 2017;12(8):e0182806.CrossRefPubMedPubMedCentral Ceuninck van Capelle A, Meide HV. Vosman FJH, Visser LH. A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS). PLoS One. 2017;12(8):e0182806.CrossRefPubMedPubMedCentral
33.
go back to reference Tintoré M, Alexander M, Costello K, Duddy M, Jones DE, Law N, O’Neill G, Uccelli A, Weissert R, Wray S. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Prefer Adherence. 2017;11:33–45.CrossRefPubMed Tintoré M, Alexander M, Costello K, Duddy M, Jones DE, Law N, O’Neill G, Uccelli A, Weissert R, Wray S. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Prefer Adherence. 2017;11:33–45.CrossRefPubMed
35.
go back to reference Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, Pugliatti M, Radice D, Goss C, Heesen C, Solari A. AutoMS group. Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PloS One. 2013;2013(8):e60721. Pietrolongo E, Giordano A, Kleinefeld M, Confalonieri P, Lugaresi A, Tortorella C, Pugliatti M, Radice D, Goss C, Heesen C, Solari A. AutoMS group. Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PloS One. 2013;2013(8):e60721.
36.
go back to reference Kasper J, Köpke S, Mühlhauser I, Nübling M, Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial. Eur J Neurol. 2008;15:1345–52.CrossRefPubMed Kasper J, Köpke S, Mühlhauser I, Nübling M, Heesen C. Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial. Eur J Neurol. 2008;15:1345–52.CrossRefPubMed
37.
go back to reference Kasper J, Heesen C, Köpke S, Fulcher G, Geiger F. Patients and observers perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. PLoS One. 2011;2011(6):e26255. Kasper J, Heesen C, Köpke S, Fulcher G, Geiger F. Patients and observers perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. PLoS One. 2011;2011(6):e26255.
38.
go back to reference Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the Patient's Agenda: Have We Improved? JAMA. 1999;281(3):283–7.CrossRefPubMed Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the Patient's Agenda: Have We Improved? JAMA. 1999;281(3):283–7.CrossRefPubMed
39.
go back to reference Langewitz W, Denz M, Keller A, Kiss A, Rüttimann S, Wössmer B. Spontaneous talking time at start of consultation in outpatient clinic: cohort study. BMJ. 2002;325(7366):682–3.CrossRefPubMedPubMedCentral Langewitz W, Denz M, Keller A, Kiss A, Rüttimann S, Wössmer B. Spontaneous talking time at start of consultation in outpatient clinic: cohort study. BMJ. 2002;325(7366):682–3.CrossRefPubMedPubMedCentral
40.
go back to reference Rieckmann P. Comparing patient and healthcare professional perceptions on multiple sclerosis management and care – where do their priorities differ? Results from a qualitative survey. ECTRIMS Online Library. 2017;200469. Rieckmann P. Comparing patient and healthcare professional perceptions on multiple sclerosis management and care – where do their priorities differ? Results from a qualitative survey. ECTRIMS Online Library. 2017;200469.
41.
go back to reference Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997;314(7094):1580–3.CrossRefPubMedPubMedCentral Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997;314(7094):1580–3.CrossRefPubMedPubMedCentral
42.
go back to reference Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Paul F, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann JP. Perceptions on the value of bodily functions in multiple sclerosis. Acta Neurol Scand. 2018;137(3):356–62.CrossRefPubMed Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Paul F, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann JP. Perceptions on the value of bodily functions in multiple sclerosis. Acta Neurol Scand. 2018;137(3):356–62.CrossRefPubMed
43.
go back to reference Kremenchutzky M, Walt L. Perceptions of health status in multiple sclerosis patients and their doctors. Can J Neurol Sci. 2013;40(2):210–8.CrossRefPubMed Kremenchutzky M, Walt L. Perceptions of health status in multiple sclerosis patients and their doctors. Can J Neurol Sci. 2013;40(2):210–8.CrossRefPubMed
44.
go back to reference Ysrraelit MC, Fiol MP, Gaitán MI, Correale J. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists. Front Neurol. 2018;8:729.CrossRefPubMedPubMedCentral Ysrraelit MC, Fiol MP, Gaitán MI, Correale J. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists. Front Neurol. 2018;8:729.CrossRefPubMedPubMedCentral
45.
go back to reference van der Linden FA, D’hooghe MB, Nagels G, Van Nunen A, Polman CH, Uitdehaag BM. Proxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life. Eur J Neurol. 2008;15(9):933–9.CrossRefPubMed van der Linden FA, D’hooghe MB, Nagels G, Van Nunen A, Polman CH, Uitdehaag BM. Proxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life. Eur J Neurol. 2008;15(9):933–9.CrossRefPubMed
46.
go back to reference Heesen C, Köpke S, Richter T, Kasper J. Shared decision making and self-management in multiple sclerosis—a consequence of evidence. J Neurol. 2007;254(S2):II116–21.CrossRefPubMed Heesen C, Köpke S, Richter T, Kasper J. Shared decision making and self-management in multiple sclerosis—a consequence of evidence. J Neurol. 2007;254(S2):II116–21.CrossRefPubMed
47.
go back to reference Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM. Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA. 1997;277(7):553–9.CrossRefPubMed Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM. Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA. 1997;277(7):553–9.CrossRefPubMed
Metadata
Title
Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
Authors
David Yeandle
Peter Rieckmann
Gavin Giovannoni
Nektaria Alexandri
Dawn Langdon
Publication date
01-12-2018
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 2/2018
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-018-0118-8

Other articles of this Issue 2/2018

Neurology and Therapy 2/2018 Go to the issue